Why the study?
Does continuous flow LVAD therapy induce autonomic dysfunction leading to orthostatic hypotension?
Does continuous flow LVAD therapy induce autonomic dysfunction leading to orthostatic hypotension?
Continuous flow LVAD therapy may induce acquired autonomic dysfunction, leading to orthostatic hypotension as an under-recognized side effect.
Answers are grounded in this paper and cite their sources.
May warrant screening for orthostatic hypotension in LVAD recipients; hypothesis-generating for pulsatility-related autonomic dysfunction and needs prospective confirmation.
Contemporary left ventricular assist device (LVAD) technology uses nonphysiologic continuous flow to deliver blood into the circulation. This results in a reduction of pulsatility, which is implicated in some of the commonly associated side effects with LVAD therapy, including hypertension and gastrointestinal arterial-venous malformation with related bleeding. A less frequently observed side effect is orthostatic hypotension (OH) in patients supported with LVAD therapy. We present three cases of OH in patients with LVAD, followed by a discussion on how LVAD therapy may induce autonomic dysfunction.
No takes yet. Share an insight, caveat, or question.
Fudim et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: